Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

198

Full text

167

Free full text

Publication Types

Journal Article

197

Research Support, Non-U.S. Gov't

102

Review

Randomized Controlled Trial

Research Support, N.I.H., Extramural

Clinical Trial

Meta-Analysis

Comparative Study

Research Support, U.S. Gov't, Non-P.H.S.

Multicenter Study

Observational Study

Controlled Clinical Trial

Research Support, U.S. Gov't, P.H.S.

Comment

Letter

Clinical Trial, Phase I

Systematic Review

Research Support, N.I.H., Intramural

Clinical Trial, Phase II

Historical Article

Editorial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Catechol O-Methyltransferase""[mesh_terms]

202 Results

Searching titles within these results

Prediction of COMT Inhibitors Using Machine Learning and Molecular Dynamics Methods.

Niladri Patra, Rakesh Kumar Roy

The journal of physical chemistry. B 2022;126(19):3477-3492

Full Text

Abstract

Separation methods for catechol O-methyltransferase activity assay: physiological and pathophysiological relevance.

Pia Pihlavisto, Ilkka Reenilä

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;781(1-2):359-72

Full Text

Abstract

Effect of Carbidopa Dose on Levodopa Pharmacokinetics With and Without Catechol-O-Methyltransferase Inhibition in Healthy Subjects.

Johanna Tuunainen, Noora Sjöstedt, Mikko Vahteristo, Juha Ellmén, Mikko Kuoppamäki, Juha Rouru, Marjo Yliperttula

European journal of drug metabolism and pharmacokinetics 2023;48(1):23-34

Full Text

Abstract

Bioactive phytoconstituent millettone as a potential inhibitor of catechol O-methyltransferase: Implications for neuroprotective therapy in Parkinson's disease.

Mohammed H Alqarni, Ahmed I Foudah, Mohammad Khalid

The Journal of pharmacology and experimental therapeutics 2025;392(6):103592

Full Text

Abstract

The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols.

Katrin Sak

Drug metabolism reviews 2017;49(1):56-83

Full Text

Abstract

Neurobiology of aggression and violence in schizophrenia.

Michael Soyka

Schizophrenia bulletin 2012;37(5):913-20

Free Full Text

Abstract

Effect of COMT inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients.

J G Nutt

Neurology 2001;55(11 Suppl 4):S33-7; discussion S38-41

Full Text

Abstract

Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics.

Dora Koller, Susana Almenara, Gina Mejía, Pablo Zubiaur, Francisco Abad-Santos, Elena Pintos-Sánchez, Elena Santos-Molina, Marcos Navares-Gómez, Dolores Ochoa, Manuel Román, Miriam Saiz-Rodríguez

Advances in therapy 2021;38(2):1035-1054

Free Full Text

Abstract

Current knowledge of anthocyanin metabolism in the digestive tract: absorption, distribution, degradation, and interconversion.

Yuehua Wang, Jinlong Tian, Bin Li, Hailong Gui, Lijun Sun, Ruihai Liu, Xu Si, Dongnan Li, Chi Shu, Xiyun Sun, Qiao Jiang, Yanyan Qiao

Critical reviews in food science and nutrition 2023;63(22):5953-5966

Full Text

Abstract

Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions.

Kathryn E Lewandowski

Harvard review of psychiatry 2008;15(5):233-44

Full Text

Abstract

The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status.

Lynn Wecker, Kelly L Sullivan, Lisa R Merlin, Robert A Hauser, Theresa A Zesiewicz

Clinical neuropharmacology 2006;29(3):106-11

Full Text

Abstract

On the nature of the transition state in catechol O-methyltransferase. A complementary study based on molecular dynamics and potential energy surface explorations.

Juan Bertrán, Iñaki Tuñón, Vicent Moliner, Maite Roca, Juan Andrés

Journal of the American Chemical Society 2005;127(30):10648-55

Full Text

Abstract

Application of kojic acid scaffold in the design of non-tyrosinase enzyme inhibitors.

Saeed Emami, Hamideh Ahadi, Reza Ahmadi, Morteza Ashooriha

Chemical biology & drug design 2022;100(2):290-303

Full Text

Abstract

Catechol-O-methyltransferase enzyme: cofactor S-adenosyl-L-methionine and related mechanisms.

Thomas Müller

International review of neurobiology 2011;95():49-71

Full Text

Abstract

Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review.

Stefano Zoccolella, Giovanni Iliceto, Michele deMari, Paolo Livrea, Paolo Lamberti

Clinical chemistry and laboratory medicine 2008;45(12):1607-13

Full Text

Abstract

Results: 1 – 15 / 202

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Catechol O-Methyltransferase""[mesh_terms]

Prediction of COMT Inhibitors Using Machine Learning and Molecular Dynamics Methods.

Separation methods for catechol O-methyltransferase activity assay: physiological and pathophysiological relevance.

Effect of Carbidopa Dose on Levodopa Pharmacokinetics With and Without Catechol-O-Methyltransferase Inhibition in Healthy Subjects.

Bioactive phytoconstituent millettone as a potential inhibitor of catechol O-methyltransferase: Implications for neuroprotective therapy in Parkinson's disease.

The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols.

Neurobiology of aggression and violence in schizophrenia.

Effect of COMT inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients.

Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics.

Current knowledge of anthocyanin metabolism in the digestive tract: absorption, distribution, degradation, and interconversion.

Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions.

The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status.

On the nature of the transition state in catechol O-methyltransferase. A complementary study based on molecular dynamics and potential energy surface explorations.

Application of kojic acid scaffold in the design of non-tyrosinase enzyme inhibitors.

Catechol-O-methyltransferase enzyme: cofactor S-adenosyl-L-methionine and related mechanisms.

Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review.

Results for
""Catechol O-Methyltransferase""[mesh_terms]